A 55-year-old overweight woman presents with a three-month history of pain in her right inferior heel. The pain is worse on taking her first steps in the morning. The physical examination is normal except for nonspecific tenderness in the region of the medial calcaneal tubercle. How should the patient be evaluated and treated?
within 12 months. 8, [20] [21] [22] Up to 5 percent of patients in reported case series are treated surgically, 3, 7, 8, 22 although reliable data on surgical rates in unselected patients are lacking.
clinical diagnosis
The diagnosis of plantar fasciitis can be made with reasonable certainty on the basis of clinical assessment alone. Patients typically report a gradual onset of pain in the inferior heel that is usually worse with their first steps in the morning or after a period of inactivity. Patients may describe limping with the heel off the ground. The pain tends to lessen with gradually increased activity but worsens toward the end of the day with increased duration of weight-bearing activity. Associated paresthesias are uncommon. Patients may report that before the onset of their symptoms, they increased the amount or intensity of their regular walking or running regimen, changed footwear, or exercised on a different surface. There is often a localized area of maximal tenderness over the anteromedial aspect of the inferior heel. Limitation of ankle dorsiflexion due to tightness of the Achilles tendon may be present. Other causes of pain in the inferior heel are usually distinguishable on the basis of history and physical examination (Table 1) . 23, 24 imaging Imaging plays a limited role in routine clinical practice, although it may be useful in selected cases to rule out other causes of heel pain or to establish the diagnosis of plantar fasciitis when it is in doubt. Occasionally, it may be difficult to differentiate plantar fasciitis from calcaneal stress fracture on clinical grounds. Plain radiographs may rule out calcaneal stress fracture and other rare bony lesions. Although the detection of heel spurs is of no value in either confirming the diagnosis of plantar fasciitis or ruling it out, a "fluffy periostitis" with illdefined borders may suggest an underlying spondyloarthropathy.
When plain radiographs are normal, bone scans are useful for distinguishing plantar fasciitis from calcaneal stress fracture. Positive findings on bone scanning for plantar fasciitis have been reported in 60 to 98 percent of cases, 25 although the false positive rate is unknown. Typical findings in the early images include increased blood flow and blood pooling; in the delayed images, findings often include a focal increase in activity at the plantar fascial insertion site in the calcaneus. By contrast, a linear fracture line or more diffuse calcaneal uptake on delayed images is consistent with calcaneal stress fractures.
Ultrasonography may be diagnostically useful, although, like other imaging techniques, it is not routinely used. The plantar fascia can be easily distinguished from the hyperechoic superficial heel pad of fat and the underlying calcaneus and is normally 2 to 4 mm thick. 26 Many studies have found a marked increase in the thickness of the plantar fascia in plantar fasciitis (to a total of approximately 5 to 7 mm) and have variably demonstrated local or diffuse hypoechogenicity at the calcaneal insertion of the plantar fascia, loss of definition at the interface between the plantar fascia and the surrounding tissue, and peri-insertion edema. 25, 26 Magnetic resonance imaging can also be used to visualize the plantar fascia, with sagittal and coronal images. 27 Normally, the plantar fascia is characterized by homogeneous low signal intensity on all pulse sequences. In plantar fasciitis, a marked increase in plantar fascial thickness can be detected, together with variable features of moderately increased signal density in the substance of the fascia on T 2 -weighted and short tau inversion-recovery pulse sequences (consistent with edema and intrasubstance microtears) and abnormally increased signal intensity in adjacent subcutaneous tissue and in the calcaneus at the plantar fascial insertion site. Markedly increased signal intensity in the calcaneus may be suggestive of plantar fasciitis associated with an underlying spondyloarthropathy. 28 
treatment
A variety of therapies are used for plantar fasciitis; however, there are few data from high-quality, randomized, controlled trials that support the efficacy of these therapies. 29 Initiation of conservative treatment within six weeks after the onset of symptoms strategies and evidence is commonly believed to hasten recovery from plantar fasciitis, 23, 24 but this is also unproved. The role of various management strategies should be considered in the light of the self-limiting nature of the condition.
Physical Therapy
Many types of physical therapy have been proposed as treatments for plantar fasciitis. 24 Support for the use of ice, heat, and massage and for strengthening of the intrinsic muscles of the foot comes predom- Posterior tibial nerve (tarsal tunnel syndrome)
Burning pain (and tenderness) that follows the path of the posterior tibial nerve inferior to the medial malleolus, radiating into the plantar aspect of the foot and toward the toes, suggests tarsal tunnel syndrome; may also radiate proximally up the leg; aggravated by prolonged weight bearing and walking on hard surfaces; reproduction of symptoms with percussion on the medial aspect of the heel (Tinel's test) suggests nerve involvement; may occur in association with plantar fasciitis inantly from anecdotal data. Stretching of the calf muscles and plantar fascia and taping or strapping of the foot are commonly recommended, but these therapies have generally been assessed in combination with other interventions, making it difficult to interpret the results of any individual intervention. A recent trial involving 101 participants showed that heel pain was either eliminated or much improved at eight weeks in 24 of 46 patients (52 percent) who were treated with an exercise program to stretch the plantar fascia, as compared with 8 of 36 patients (22 percent) who reported such results after participating in a program to stretch the Achilles tendon. 30 However, the study was not blinded, there was a large difference in the dropout rate between the groups (28 percent in the group in which patients stretched the Achilles tendon and 10 percent in the group in which patients stretched the plantar fascia), and only those who completed the trial were included in the analysis. Two randomized, placebocontrolled trials 31, 32 did not demonstrate a benefit of using magnetic insoles, and small randomized, placebo-controlled trials 29 found no significant benefit of ultrasonography, laser treatment, iontophoresis, or exposure to an electron-generating device.
Orthotic Devices
A wide variety of prefabricated and custom-made orthoses, including heel pads and cups that are variously designed to elevate and cushion the heel, provide medial arch support, or both, are used to treat plantar fasciitis. There are no data on the efficacy of these devices as compared with placebo or no treatment, and the available data on their efficacy in comparison with that of other interventions are conflicting or limited. One study, involving 103 patients, compared mechanical treatment (taping and orthoses) with the use of a heel cup or antiinflammatory treatment (three corticosteroid injections administered at weekly intervals, plus nonsteroidal therapy). Among the 77 patients who completed the trial, mechanical treatment was more effective in achieving an outcome rated as "excellent" or "fair" at three months (reported for 19 of 27 patients, or 70 percent) than was use of the heel cup (7 of 23 patients, or 30 percent) or antiinflammatory treatment (9 of 27 patients, or 33 percent). 33 In a trial involving 236 participants, prefabricated shoe inserts (a silicone cone, felt pad, or rubber heel cup) were found to be superior both to using custom-made orthotic devices and to stretching alone. (The percentages of patients whose condition had improved at eight weeks were 95 percent for a silicone-cone insert, 88 percent for a felt pad, 81 percent for a rubber heel cup, 68 percent for custom-made orthotic devices, and 72 percent for stretching alone. 2 )
Splinting and Walking Casts
The use of night splints, designed to keep the ankle in a neutral position with or without dorsiflexion of the metatarsophalangeal joints during sleep, has been evaluated in two randomized, controlled trials, with conflicting results. 34, 35 One trial involving 116 participants showed no benefit of a night splint worn for three months as compared with no treatment. 35 In contrast, a crossover trial involving 37 participants suggested a benefit of a night splint worn for one month as compared with no treatment. 34 However, a crossover design may not be a valid method for studying interventions for treatment of a self-limiting condition. A third trial involving 255 participants showed no benefit of a posterior tension splint used at night as compared with either custom-made orthoses or over-the-counter arch supports. 36 There are no published data from controlled trials of immobilization with casts or other devices. A retrospective review reported a recurrence of pain, usually within a month after cessation of the use of a plaster cast, in 11 of 24 patients (46 percent) for whom follow-up data were available. 37 
Antiinflammatory Agents
Nonsteroidal antiinflammatory drugs are often used in practice, but randomized trials have not been conducted to assess their benefit. The injection of corticosteroids, usually mixed with local anesthetic and injected with the use of a medial approach, is another common treatment for heel pain. 29 Limited data suggest that this treatment provides only shortterm pain relief. One trial, involving 91 participants, showed that 1 ml of prednisolone acetate (25 mg) with 1 ml of local anesthetic, injected with the use of a medial approach, resulted in significantly greater improvement in pain at one month than did injection of local anesthetic alone; the mean (±SD) changes in the pain score, measured on a 10-cm visual-analogue scale, were 2.0±2.9 and 0.06±3.0, respectively. 29 At three and six months, there were no differences between the groups in pain measures, but a high rate of loss to follow-up precluded the drawing of conclusions. A tibial-nerve block given before injection did not appear to reduce the discomfort of the injection. One concern is that corticoste-roid injections may be associated with an increased risk of rupture of the plantar fascia, 38,39 although data to support this association are limited and inconclusive. 13, 38 Extracorporeal Shock-Wave Therapy
Extracorporeal shock-wave therapy has been proposed as an alternative approach on the grounds that it may stimulate healing of soft tissue and inhibit pain receptors. 40 However, the available data do not provide substantive support for its use. Of six randomized, double-blind, placebo-controlled trials assessing the efficacy of extracorporeal shockwave therapy, [40] [41] [42] [43] [44] [45] three studies (involving 166, 272, and 88 participants) showed no benefit, 40, 43, 44 and two studies (involving 150 and 302 participants) reported small benefits that were of questionable clinical importance. 41, 42 A sixth trial, involving 45 runners, showed that extracorporeal shock-wave therapy, as compared with placebo, resulted in a significant reduction in the score for pain on first walking in the morning (a mean reduction of 2.6 on a 10-cm visual-analogue scale) at six months. 45 
Surgery
Surgery may be considered for a small subgroup of carefully selected patients who have persistent, severe symptoms despite nonsurgical intervention for at least 6 to 12 months. The surgical procedures used for plantar fasciitis include variations of open or closed partial or complete plantar fascia release with or without calcaneal spur resection, excision of abnormal tissue, and nerve decompression. 46, 47 In case series, favorable outcomes were reported in more than 75 percent of patients who underwent surgery, although the recovery times varied and were sometimes months, 48 and persistent pain occurred in up to a quarter of patients who were followed for an average of two or more years. Patients, such as the woman in the introductory vignette, who have symptoms and signs consistent with plantar fasciitis -including heel pain that worsens on first walking in the morning and tenderness over the anteromedial aspect of the inferior heel -should be informed that the condition is self-limiting and that in more than 80 percent of patients, the symptoms will resolve within a year, regardless of therapy. Since there is limited evidence about the value of treatments for plantar fasciitis, a reasonable approach to intervention is to start with patient-directed, low-risk, minimal-cost interventions, such as regularly stretching the calf muscles and the plantar fascia, avoiding flat shoes and walking barefoot, using over-the-counter arch supports and heel cushions, and limiting extended physical activities. A trial of nonsteroidal antiinflammatory drugs may be reasonable. Corticosteroid injections may provide a short-term benefit.
More costly treatments -such as the use of custom-made orthotic devices, night splints, and immobilization with casts or other devices -may be options for patients in whom the condition does not improve, although the value of these treatments is currently uncertain. Surgery should be reserved for those patients whom conservative therapy has not helped after 6 to 12 months. In the absence of data to guide the surgical approach, referral to a surgeon with expertise in treating patients with plantar fasciitis is recommended. 
